CFAR Adelante Program

Project Scope

Project Scope

Proposed research projects must be aligned with the NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding (the Priorities) and should address Latina/x/o-population needs in the United States. Proposed research projects also aligned with the federal Ending the HIV Epidemic in the U.S. (EHE) Initiative, located in EHE priority jurisdictions, and addressing Latina/x/o population needs in the United States, will also be considered. International research may be allowed if it is a small subset of a larger domestic study. For more information about international research see the FAQ page.

The proposed research project should be achievable within a 20-month research implementation period.

Eligible research topics may include but are not limited to:

  • Developing, testing, and implementing strategies to improve HIV testing and entry into prevention services by Hispanic and/or Latina/x/o people.
  • Long-term prevention strategies specific to Hispanic and/or Latina/x/o populations for HIV-relevant coinfections and comorbid conditions across the lifespan
  • Effective socio-behavioral interventions to achieve uptake of HIV prevention and treatment strategies by Hispanic and/or Latina/x/o people and reduce health disparities among the population.
  • Implementation research tailored specifically for Hispanic and/or Latina/x/o populations that are designed to ensure that biomedical and other prevention and treatment strategies are initiated as soon as possible, that retention and engagement in treatment services is increased, and/or that maintenance of optimal prevention and treatment responses are achieved.
  • Research that examines HIV-related health and social issues in Hispanic and/or Latina/x/o populations, such as other infectious or non-infectious conditions and substance use or mental health disorders that are clearly linked with HIV (transmission/acquisition, pathogenesis, morbidity and mortality, stigma) in sub-populations or settings with high HIV prevalence or incidence.

Clinical trials, as defined in NOT-OD-15-015, cannot be funded. This includes any research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. If you are unsure if your approach meets the NIH clinical trial definition, use the NIH decision tool for determining if a study meets the definition of a clinical trial.

Some clinical research will require additional NIH reviewSee the FAQ page for more information. If an applicant is unsure if their proposed approach qualifies as clinical research or a clinical trial, or if it will require additional NIH CFAR clinical review, please contact Jenny Anderson, the CFAR Adelante Post-Award Project Coordinator ( 

Contact Us

Center for AIDS Research at Emory University
1518 Clifton Rd, NE
Suite 8050
Mailstop: 1518-002-8BB
Atlanta, GA 30322-4201
404.727.2924  |